Active Ingredient History
The olive, botanical name Olea europaea, meaning 'European olive', is a species of small tree or shrub in the family Oleaceae, found traditionally in the Mediterranean Basin. When in shrub form, it is known as Olea europaea 'Montra', dwarf olive, or little olive. The species is cultivated in all the countries of the Mediterranean, as well as in Australia, New Zealand, North and South America and South Africa. It is the type species for its genus, Olea. The tree and its fruit give their name to the Oleaceae plant family, which also includes species such as lilac, jasmine, forsythia, and the true ash tree. Wikipedia
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 2)
Biological Availability (Phase 1/Phase 2)
Blood Glucose (Phase 1)
Bone Diseases, Metabolic (Phase 4)
Brain (Phase 4)
Brain Diseases (Phase 2)
Cardiovascular Diseases (Phase 3)
Central Nervous System Diseases (Phase 2)
Cognition (Phase 4)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 2)
Colonoscopy (Phase 4)
COVID-19 (Phase 2)
Dementia (Phase 2)
Depression (Phase 3)
Dermatitis (Phase 1/Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Dietary Supplements (Phase 1)
Disseminated Intravascular Coagulation (Phase 2)
Dry Eye Syndromes (Phase 4)
Dyslipidemias (Phase 4)
Enteral Nutrition (Phase 1/Phase 2)
Fatty Acids (Phase 4)
Functional Food (Phase 1/Phase 2)
Healthy Volunteers (Phase 1/Phase 2)
Hemodialysis, Home (Phase 4)
Hypercholesterolemia (Phase 4)
Hyperglycemia (Phase 4)
Hypertension (Phase 4)
Hypertriglyceridemia (Phase 3)
Infant, Premature (Phase 2/Phase 3)
Inflammation (Phase 2)
Keratoconjunctivitis Sicca (Phase 2/Phase 3)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 1)
Low Back Pain (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Mental Disorders (Phase 2)
Metabolic Syndrome (Phase 4)
Neonatal Sepsis (Phase 2/Phase 3)
Nervous System Diseases (Phase 2)
Neurocognitive Disorders (Phase 2)
Neurosciences (Phase 4)
Nutritional Physiological Phenomena (Phase 1/Phase 2)
Obesity (Phase 4)
Obstetric Labor, Premature (Phase 2)
Osteoarthritis, Knee (Phase 2)
Osteoporosis (Phase 2)
Oxidative Stress (Phase 1)
Papillomavirus Infections (Phase 2)
Parenteral Nutrition (Phase 4)
Pathologic Processes (Phase 2)
Pemphigoid, Bullous (Phase 3)
Pemphigus (Phase 3)
Periodontal Diseases (Phase 2)
Periodontitis (Phase 1/Phase 2)
Physiology (Phase 1)
Polycystic Ovary Syndrome (Phase 4)
Pregnancy (Phase 3)
Pressure Ulcer (Phase 4)
Psoriasis (Phase 2/Phase 3)
Radiodermatitis (Phase 4)
Schizophrenia (Phase 4)
Sepsis (Phase 2/Phase 3)
Signs and Symptoms (Phase 2)
Sjogren's Syndrome (Phase 4)
Stomatitis (Phase 1)
Tobacco Use Disorder (Phase 2)
Tooth Movement Techniques (Phase 1)
Vitamin D Deficiency (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
